Previous work has shown that prolonged pretreatment of a mouse anterior pituitary cell line, AtT-20 cells, with the cytokine interleukin 1 (IL-1) stimulates /3-endorphin release and potentiates the secretion induced by many secretagogues. Prolonged treatment with IL-1 abolishes the capacity of cytokine to induce the phosphorylation of 20-and 60-kDa proteins.
The cytokine interleukin 1 (IL-1) is an important messenger molecule in the immune system and possibly the nervous and endocrine systems. It has been recently demonstrated that human recombinant IL-1, after a long pretreatment (at least 18 hr), stimulates the release of f-endorphin in AtT-20 cells (1) . Previous work in our laboratory has shown that prolonged pretreatment with IL-1 also potentiates the secretion induced by secretagogues such as corticotropin-releasing factor (CRF), vasoactive intestinal peptide, forskolin, norepinephrine, isoproterenol, and phorbol ester [phorbol 12- by IL-1 (1). These observations suggested that the mechanism by which IL-1 enhanced TPA-induced,-endorphin secretion was mediated by increasing PKC activity.
This report shows that IL-1 induces an early phosphorylation of three proteins, independent of PKC and cAMPdependent kinase. Once an early signal is triggered by IL-1, its presence is no longer required for subsequent B-endorphin secretion.
MATERIALS AND METHODS
Cell Culture. AtT-20/D16-16 mouse anterior pituitary tumor cells, obtained from S. Sabol (National Heart, Lung and Blood Institute, Bethesda, MD), were grown in Dulbecco's modified Eagle medium (DMEM) containing 4.5 g of glucose per liter, 10% fetal bovine serum, penicillin (100 units/ml), and streptomycin (100 ,g/ml). The cells were maintained in a humidified atmosphere of 10% CO2 at 37°C. For /-endorphin release experiments the cells were subcultured in 24-well Costar plates at an initial density of 105 cells per well and were used [5] [6] [7] days later (80-90% confluency). For phosphorylation experiments, the cells were subcultured in 6-well Costar plates at an initial density of 2 x 105 cells per well and were grown to -75% confluency. CRF and TPA in 100-fold stock solution were diluted to final concentrations of 0.1 ,uM in the culture wells. IL-la final concentration in all experiments was 1 nM.
Phosphorylation Experiments. AtT-20 cells were preincubated for 15 min in phosphate-free DMEM and then labeled for 45 min with 100 ,uCi of [32P]orthophosphate per ml (1 Ci = 37 GBq) in phosphate-free DMEM or phosphate-free Krebs-Ringer buffer. Secretagogue solutions were added and, after incubation periods ranging from 5 to 120 min, the cells were dissolved in a buffer containing 50 mM Tris phosphate, 100 mM NaF, 10 mM EDTA, 5 mM EGTA, 4 mg of leupeptin per liter, and 1% (vol/vol) Triton X-100 (pH 7.4). Cytosolic fractions were obtained by centrifugation of cell homogenates (15, 000 rpm, 5 min) followed by collection of the supernatants. After precipitation ofproteins with ice-cold 6% trichloroacetic acid (TCA) and a second centrifugation step (15,000 rpm, 5 min), the resulting pellets were homogenized twice in 50% ethanol/50% diethyl ether using a sonicator, which was followed each time by centrifugation (15,000 rpm, 5 min). Pellets were then resuspended in phosphate-buffered saline, aliquots were removed for determination of protein concentration, and the remainder of the samples was lyophilized and stored overnight at -30°C. Two-Dimensional Gel Electrophoresis. After adjusting protein concentrations, TCA-precipitated cytosolic proteins were homogenized in sample buffer containing 5% 2-mercaptoethanol, 2% Nonidet P-40, 9 M urea, and bromophenol blue. After a brief centrifugation to remove particulate matter, aliquots of the samples (-150,000 cpm) were applied to a 0.5-mm isoelectric focusing (IEF) gel slab containing 8 M urea, 6% acrylamide, and 5% pH 3.5-9.5 Ampholines. IEF was performed at 12.50C using 1 M NaOH and 1 M H3PO4 for cathode and anode solutions, respectively. IEF gels were run for -1.5 hr at 20 W constant power as described (2). The sample lanes were then sliced, sprayed with an SDScontaining loading buffer, and run on standard 12.5% acrylamide gels. These second-dimension gels were run for -2.5 hr at 40 mA per gel, and proteins were stained with Coomassie brilliant blue R-250, dried in slab gel driers, and exposed to x-ray film. After exposure times ranging from 1 to 5 days, films were developed and the optical densities (ODs) of the radiographic images were quantitated by densitometry as described (2) . ODs of phosphoproteins resolved on the two-dimensional gels were normalized by dividing each OD by the total OD measured for the entire autoradiogram to facilitate comparisons of autoradiograms from different experiments.
(8-Endorphin Release Experiments. At the onset of each experiment, freshly prepared 10% fetal bovine serum/ DMEM with or without IL-1 was added to the cells and the incubation was continued for the times indicated. Then, AtT-20 cells were washed twice with 1 ml of 0.2% bovine serum albumin/DMEM to remove the large amounts of P-endorphin released during the long pretreatment period and incubated in identical serum-free medium in the presence or absence of IL-1 with or without other secretagogues for 60 min. The test medium was collected separately from each well and centrifuged, and the supernatant fluids were stored at -20TC until analysis by radioimmunoassay (3) . The antiserum was kindly provided by G. Meuller (Uniformed Services University of the Health Sciences, Bethesda, MD). Results were expressed as ng per well per hour. Data representing 8-endorphin secretion induced by secretagogues were calculated by subtracting the amount offendorphin released by untreated cells.
cAMP Studies. AtT-20 cells were grown in six-well culture plates until about 90% confluent and the culture medium was replaced with serum-free DMEM containing 0.2% bovine serum albumin and 250 ,uM 3-isobutyl-1-methylxanthine (IBMX). The cells were then incubated for 30 min followed by the addition of the secretagogues indicated. After incubation periods ranging from 5 to 60 min, the treatment medium was aspirated and 1 ml of ice-cold 10 mM acetic acid/250 ,uM IBMX was added. The cells were kept frozen, thawed briefly for homogenization via sonication, and centrifuged (5 min, 14,000 rpm). Aliquots of supernatants were Iyophilized for subsequent cAMP determination by RIA.
Statistical Analysis. Experiments for f3-endorphin secretion and cAMP accumulation were performed in 24-and 6-well plates. Each experimental manipulation was carried out in three to six wells. The values obtained were averaged and considered as a single observation. Data presented are means ± SEM. Statistical comparisons were made by Student's t test. For phosphorylation studies, each treatment combination was performed in three experiments using duplicate culture wells that were individually processed to autoradiograms. The OD data were analyzed by analysis of variance followed by post hoc tests (Scheffe).
Materials. DMEM, fetal bovine serum, L-glutamine, penicillin/streptomycin, and phosphate-buffered saline without Ca2+/Mg2+ were obtained from GIBCO; CRF was purchased from Peninsula Laboratories; forskolin, TPA, and bovine serum albumin (RIA grade) were obtained from Sigma;
[32P]orthophosphate, 1251-labeled P-endorphin, and cAMP RIA kits were from New England Nuclear. IL-la was generously provided by P. Lomedico (Hoffmann-La Roche) and IL-183 was a gift of Y. Hirai (Otsuka Pharmaceuticals). Desensitization of PKC by prolonged treatment with TPA only partly abolished the effect of CRF alone as well as the potentiating effects induced by IL-1. Pretreatment with TPA did not abolish P-endorphin secretion induced by IL-1 alone (Fig. 1) . These observations are in contrast to those obtained with TPA and TPA together with IL-1, where desensitization of PKC abolished the secretory effects of TPA as well as the potentiating effect on TPA-elicited secretion induced by pretreatment with IL-1 (1) .
From these data it appears that the action of IL-1 and the potentiating effect of IL-1 on CRF-induced 8-endorphin secretion involve other mechanisms in addition to activation of PKC.
IL-1 Induces Early Protein Phosphorylation in AtT-20 Cells. Because of the complexity of these signaling events triggered by IL-1 on secretagogue-induced 3-endorphin release, we examined whether other protein kinases were involved.
We studied the effects of IL-1 alone on the activation of protein kinases by determining its action on protein phosphorylation in AtT-20 cells using two-dimensional gel electrophoresis. Treatment of the cells with IL-la for 15 min resulted in increased 32p incorporation in several acidic cytosolic proteins with the relative molecular masses 60 kDa, 43 kDa, 39 kDa, 20 kDa, and 19 kDa. A subset of these proteins, the 60-kDa, 20-kDa, and 19-kDa species, exhibited marked (5-fold) increases in phosphorylation levels (Fig. 2) . Other fl-endorphin secretagogues, such as CRF, TPA, and forskolin, also increased the phosphorylation of the 19-kDa and the 20-kDa proteins (data not shown), but the 60-kDa protein was only responsive to IL-1.
To investigate whether the 87-kDa phosphoprotein is a substrate for PKC and to verify that PKC can be desensitized by prolonged treatment with TPA, AtT-20 cells were pretreated with phorbol ester for 24 hr, washed, and then treated with TPA for 15 min. Pretreatment with phorbol ester for 24 hr abolished the ability of further treatment with TPA to phosphorylate the 87-kDa protein. In contrast, treatment of control cells with TPA for 15 min caused a marked increase in phosphorylation of the 87-kDa protein (Fig. 3) . These results indicate that the 87-kDa protein is a substrate for PKC and that TPA has the capacity to desensitize this enzyme.
To examine the effects of IL-1 on cytosolic protein phosphorylation in AtT-20 cells, a time course of the effect of IL-la on protein phosphorylation was measured. The phosphorylation of the 20-kDa protein was found to be stimulated as early as 15 min and stimulated maximally after 60 min. The phosphorylation of the 60-kDa protein was maximally stimulated after 15 min, possibly earlier, and returned to basal levels after 2 hr (Fig. 4) .
The effect of desensitization of PKC on phosphorylation of the 20-, 60-, and 87-kDa proteins induced by a 15-min treatment with IL-1 was then studied. AtT-20 cells were pretreated 24 hr with TPA, washed, and then exposed to IL-la for 15 min. Desensitization of PKC by TPA pretreatment had no effect on the ability of IL-1 to induce the phosphorylation of the 20-and the 60-kDa proteins (Fig. 5) .
Another protein kinase that could possibly be involved in IL-i-elicited phosphorylation is cAMP-dependent protein kinase. It was previously shown that many secretagogues, such as CRF, norepinephrine, and forskolin, act primarily through generation of cAMP in AtT-20 cells (14) . Because of this association, we investigated whether or not IL-1 can induce the phosphorylation of the above proteins by way of the generation ofcAMP. AtT-20 cells were treated with IL-la over a period of 1 hr in the presence of the phosphodiesterase inhibitor IBMX. CRF alone increased the production of cAMP, but IL-1 failed to generate cAMP. This suggested that cAMP-dependent protein kinase is not involved in the phosphorylation of these proteins ( Table 1 ).
The Ability of IL-1 to Phosphorylate Proteins Can Be Desensitized. We previously found that the potentiating effect of IL-1 on secretagogue-induced 8-endorphin secretion is apparent only after 18 hr and is maximum at 24 hr. An experiment was designed to investigate whether IL-1 can still generate an early signal, the phosphorylation of the 20-and 60-kDa proteins after its continuous presence with AtT-20 cells for 24 hr, when the cytokine exerts its maximum potentiating effect on secretagogue-induced secretion. AtT-20 cells were pretreated for 24 hr with IL-la, thoroughly washed, and treated again with IL-la for 15 min. After prolonged pretreatment with IL-1, the capacity of IL-1 to induce the phosphorylation of 20-and 60-kDa proteins was abolished (Fig. 6) .
The Continuous Presence of IL-1 Is Not Necessary for Late Induced P-Endorphin Secretion. The early signal, protein phosphorylation by IL-1, appears to generate a cascade of events that do not require the continuous presence of IL-1. We examined whether the continuous presence of IL-1 was necessary for the late induced secretion of P-endorphin. After 6 hr of treatment of AtT-20 cells with IL-la, there was no increase in 8-endorphin secretion induced by IL-1. At that time the cells were thoroughly washed to remove IL-1, and IL-1-free medium was added. Eighteen hours after the cells were washed, those cells that were initially treated with IL-1 secreted a significantly greater amount of f3-endorphin than the basal levels and at the same magnitude as was found when IL-1 was continuously present (Table 2) . DISCUSSION The requirement for a prolonged treatment with IL-1 to increase 3-endorphin secretion necessitates a sequence of IL-1-mediated early and late signals. It has been recently demonstrated that IL-1 can increase the formation of mRNA for pro-opiomelanocortin only after treatment with the cytokine for a long period of time (4) . This late event most likely requires early receptor-mediated signals. Information concerning the early signals that IL-1 generates and biochemical events following IL-1 receptor interaction is scanty. Some of the data described appear to be contradictory and no clear picture has yet emerged (5). It has been shown that IL-1 induces tyrosine phosphorylation of a 41-kDa plasma membrane protein of the human tumor cell line K562 (6) . Another laboratory has observed the phosphorylation of a cytosolic 65-kDa protein induced by IL-1 in glucocorticoid-pretreated normal human peripheral blood mononuclear leukocytes (7). IL-1 was found to stimulate the production of diacylglycerol and phosphatidic acid in cultured rat mesangial cells (8) , prostaglandin synthesis in fibroblasts (9) , cAMP synthesis in YT cells (a human natural killer-like cell line) (10) , and PKC activity in fibroblasts (9) . Others have not observed PKC activation by IL-1 (11) .
We have observed that IL-1 can activate protein kinases in AtT-20 cells, which then markedly phosphorylate 19-, 20-, and 60-kDa proteins within minutes in a time-dependent manner. The 20-kDa protein is probably a more heavily phosphorylated form of 19-kDa protein, exhibiting the characteristic acidic shift on two-dimensional gels. The 20-kDa and 19-kDa proteins have been shown to respond to a number of different secretagogues, and it has been suggested that these proteins participate in secretory pathways (2, 12) . Recently, a 19-kDa protein exhibiting an electrophoretic profile similar to the proteins described here was isolated and sequenced (13) . This protein (stathmin) has been proposed to serve as an intracellular relay for diverse extracellular signals, cell differentiation, and secretion by various second messenger pathways (13) .
pB-Endorphin secretagogues in AtT-20 cells can generate cAMP and/or activate PKC (14) . Desensitization of PKC abolished the potentiating effect of IL-1 on TPA-induced ,f-endorphin secretion and partly reduced the potentiating effect of IL-1 on CRF-induced f-endorphin secretion. This suggests that PKC, as well as other kinases, could be involved in early IL-1-signaling mechanisms. An examination of protein phosphorylation induced by IL-1 in AtT-20 cells indicated that this effect does not directly involve PKC or cAMP-dependent protein kinase. Prolonged treatment with TPA, which was found to abolish 87-kDa protein phosphorylation, had no effect on IL-1-induced phosphorylation of the 20-, 60-, and 87-kDa proteins, indicating that the phosphorylation of these proteins is independent of PKC activation. IL-1 did not generate cAMP, suggesting that 
